| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000038805 |
| Receipt No. | R000041773 |
| Scientific Title | Japan Mako THA study |
| Date of disclosure of the study information | 2019/12/06 |
| Last modified on | 2021/10/27 (Ver. 3) |
| Basic information | ||
| Public title | Japan Mako THA study | |
| Acronym | Japan Mako THA study | |
| Scientific Title | Japan Mako THA study | |
| Scientific Title:Acronym | Japan Mako THA study | |
| Region |
|
|
| Condition | ||
| Condition | Hip osteoarthritis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate accuracy/precision of implant placement of Mako system in Japanese population |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 1. The discrepancy between pre-operative plan and post-operative implant position indicated in Mako system
2. The discrepancy between implant position indicated in Mako system and post-operative CT evaluation. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. The patient who will receive/received THA with Mako system.
2. The patient has signed the IRB approved, study specific informed patient consent form. (Not applicable if the site allows to enroll subject retrospectively or the patient has already received THA with Mako system.) 3. The patient who is willing to participate the study during the follow-up period. (Not applicable if the site allows to enroll subject retrospectively or the patient has already received THA with Mako system.) |
|||
| Key exclusion criteria | NA | |||
| Target sample size | 400 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Osaka University Graduate School of Medicine | ||||||
| Division name | Orthopedic Medical Engineering | ||||||
| Zip code | 565-0871 | ||||||
| Address | 2-2, Yamakaoka, Suita, Osaka, Japan | ||||||
| TEL | 06-6879-3271 | ||||||
| n-sugano@umin.net | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Stryker Japan K.K. | ||||||
| Division name | Clinical Affairs | ||||||
| Zip code | 112-0004 | ||||||
| Address | 2-6-1, Koraku, Bunkyo-ku, Tokyo | ||||||
| TEL | 03-6894-8394 | ||||||
| Homepage URL | |||||||
| NSKclinicaltrial@stryker.com | |||||||
| Sponsor | |
| Institute | Stryker Japan K.K. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Stryker Japan K.K. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Osaka University Clinical Research Review Committee |
| Address | 2-2, Yamadaoka, Suita City, Osaka Prefecture |
| Tel | 06-6210-8296 |
| rinri@hp-crc.med.osaka-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | The evaluation will be conducted with procedure related information and x-ray/CT imaging under general medical care. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000041773 |